Stock Screener
Home
Account
Top Lists
Favorites
Best Portfolios
Screener
Portfolios
News
School
CTMX - CytomX Therapeutics, Inc.
$0.6772
0% ($0)
0
-5.1
-1.7
0.2
-0.6
0
0.9
BP
DE
PE
EPS
ROE
BVPS
CURRENT
Choose a Financial Catagory:
cash
wages
assets
equity
revenues
liabilities
fixed_assets
net_cash_flow
current_assets
net_income_loss
accounts_payable
noncurrent_assets
costs_and_expenses
operating_expenses
current_liabilities
basic_average_shares
other_current_assets
operating_income_loss
diluted_average_shares
liabilities_and_equity
noncurrent_liabilities
benefits_costs_expenses
other_noncurrent_assets
net_cash_flow_continuing
other_operating_expenses
research_and_development
comprehensive_income_loss
other_current_liabilities
income_tax_expense_benefit
equity_attributable_to_parent
other_comprehensive_income_loss
net_income_loss_attributable_to_parent
net_cash_flow_from_financing_activities
net_cash_flow_from_investing_activities
net_cash_flow_from_operating_activities
equity_attributable_to_noncontrolling_interest
preferred_stock_dividends_and_other_adjustments
comprehensive_income_loss_attributable_to_parent
income_loss_from_continuing_operations_after_tax
income_loss_from_continuing_operations_before_tax
net_cash_flow_from_financing_activities_continuing
net_cash_flow_from_investing_activities_continuing
net_cash_flow_from_operating_activities_continuing
net_income_loss_available_to_common_stockholders_basic
net_income_loss_attributable_to_noncontrolling_interest
comprehensive_income_loss_attributable_to_noncontrolling_interest
participating_securities_distributed_and_undistributed_earnings_loss_basic
Address:
Portfolio: